fbpx
header
Good morning, 360
As always, we keep an eye on the biggest movers and the top headlines in the Market. Be the best prepared Trader on the Street! Have a great day, 360!
focus list
INAB – Up over 37% in pre-market after H.C. Wainwright reiterates BUY rating, $14 price target
CMND – Up over 39% in the pre-market this after announcing a collaboration and patent application for treatment of depression with SPRC on Friday
APLM – 2nd day play, closed up over 59% after E.F. Hutton initiated coverage with a BUY rating and $25 target yesterday
You too, like Aaron, can get Jeff’s next 13 BullseyeTrades of the Week
For a measly $47!!!
Altered (but were totally sure hes thinking this)
Don’t worry, Aaron we got you!
Come see why Jeff Bishop is rated 4.8/5潃 on TrustPilot, and check out why people love BOTHBullseye Trades & Wall Street Bookie (where Jeff has won his last 18 options selling trades* –scintillating).
*at the time of writing this ad April 25th
hotlist
INAB – Up over 37% in pre-market after H.C. Wainwright reiterates BUY rating, $14 price target
IN8bio (INAB) is up 37% in pre-market after H.C. Wainwright reiterated its BUY rating and $14 price target. On Monday, the company presented new data for its drug INB-100 showing long-term complete remissions and elevated Gamma-Delta T Cells in 100% of evaluable treated leukemia patients (n=7) including high-risk acute myeloid leukemia (AML) patients and a patient with acute lymphoblastic leukemia (ALL) who had failed 4 prior lines of therapy, including CAR-T, with all evaluable patients remaining alive at last assessment and one patient out beyond 3 years.
The stock closed up over 200% on Monday, before falling 37% yesterday. It has since recovered yesterday’s losses so far in the pre-market on the reiteration. Any large shorts that did not cover yesterday could be in trouble today.
chart
The $2.50 area was support on Monday and again in the pre-market this morning and will be an important level to watch.
Above it, targets to the upside are $2.88, $3, $3.25, $3.40, $3.70 and then Mondays high of $3.95. Beyond that, $4.50 and $5 come into play.
Below $2.50, there is potential support at $2.05, $2 and $1.90. Below that targets to the downside are $1.60, $1.40 and a gap to fill at $1.05.
CMND – Up over 39% in the pre-market this after announcing a collaboration and patent application for treatment of depression with SPRC on Friday
Clearmind Medicine (CMND) announced a patent application for the treatment of depression with SPRC on Friday. CMND is focused on the development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems
While SPRC has been up over 20% since Friday and over 50% over the last few weeks, CMND has been trading sideways. Its doing some catching up this morning.
MNMD, another psychedelics play is also up over 20% the last few days. This sector may just be starting to heat up.
CMND and SPRC filed a patent relating to the protection of the unique combination of MEAI and SciSparc’s (SPRC) palmitoylethanolamide for the treatment of depression, alcohol and drug addiction.
chart
The $0.74 area was support in the pre-market and will be a pivot point to watch.
Above it, targets to the upside are $0.80, $0.85, $0.90, $0.94, $1 and then the pre-market high of $1.04. Beyond that, $1.20, $1.40 and $1.50 come into play.
Below $0.74, there is potential support at $0.70, $0.64 with a gap to fill at $0.5520.
APLM – 2nd day play, closed up over 59% after E.F. Hutton initiated coverage with a BUY rating and $25 target yesterday
Apollomics (APLM) received a BUY rating and $25 target from E.F Hutton yesterday and closed 59% on the news. The $25 target still represents over 300% upside from yesterdays close.
APLM is a recent SPAC merger aimed at supporting candidates targeting difficult to treat cancers.
The stock is a prior runner, that traded above $40 on Mar 30, 2023, the day of the merger.
chart
The $5.55-$5.40 zone was a support area during trading hours yesterday, in the after-hours and in pre-market this morning so is an important level to watch.
Above it, targets to the upside are at $6, $6.20, $6.50. Beyond that, $8 and then $12 come into play.
Below $5.40, the is potential support at $5.20, $5, $4.80, and then $4.50.
market news
Economic Calendar
calendar
To Your Success!
Author:
Editor

Leave your comment

Skip to content